Although JAK2 is not essential for disease maintenance in CML [45], it still has the potency to phosphorylate STAT5 and is part of a complex with the BCR-ABL1 network [46, 47]. The gene discussed is STAT5B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.